cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma of the uterine cervix; 2. Patients with FIGO stage IA2, IB1 or IIA1 disease; 3. Patients with adequate bone marrow, renal and hepatic function: WBC > 3,000 cells/mcl, Platelets>100,000/mcl, Creatinine 5 years previous with no current evidence of disease; 7. Females aged 18 years or older.
Exclusion criteria
Exclusion criteria: 1. Any histological type other than adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma of the uterine cervix; 2. Tumor size greater than 4 cm; 3. FIGO stage IB2, IIA2 and II-IV; 4. Patients with a history of pelvic or abdominal radiotherapy; 5. Patients who are pregnant; 6. Patients with contraindications to surgery; 7. Patients with evidence of metastatic disease by conventional imaging studies, enlarged pelvic or aortic lymph nodes > 2cm; or histologically positive lymph nodes; 8. Unfit for Surgery: serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator); 9. Patients unable to withstand prolonged lithotomy and steep trendelenburg position; 10. Patient compliance and geographic proximity that do not allow adequate follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative quality of life;the function of Urination and defecation;Progression free survival;the function of pelvic floor; | — |
Countries
China
Contacts
The First Affiliated Hospital of Sun Yat-sen University